We investigated whether the amount of circulating cell-free fetal DNA in ma
ternal serum is influenced by fetal karyotype, using real-time quantitative
polymerase chain reaction assay. Serum samples were obtained from pregnant
women at gestational ages ranging from 15 to 17 weeks, prior to their unde
rgoing amniocentesis. In total, we examined 70 samples consisting of 55 cas
es of pregnancy with 46,XY, 5 cases with 47,XY,+21, 3 cases with 47,XY,+18,
a single case with 46,XY,dup(1) and 2 cases with twins of 46,XY, and 4 cas
es with 46,XX which were used as negative controls. We measured the concent
ration of the SRY sequence as a molecular marker for fetal DNA. The SRY seq
uence was detectable and measurable when the fetuses were male except for o
ne case with 47,XY,+18 This case showed fetal growth retardation and bradyc
ardia. No amplification signals of the SRY sequence were detected when the
fetuses were female. The mean concentration of fetal DNA in maternal serum
was 31.5 copies/ml in the pregnancy with 46,XY, 23.5 copies/ml in the pregn
ancies with 47,XY,+21 and 21.5 copies/ml in the pregnancies with 46,XY,+18.
There were no significant differences in the concentration of fetal DNA be
tween pregnancies with fetuses of normal karyotype and those with fetuses o
f abnormal karyotype.